The effects of cisplatin in triple negative breast cancer cells /

The effects of cisplatin in triple negative breast cancer cells /

Show other versions (1)

Project Paper (Sarjana Muda Sains (Biologi)) - Universiti Teknologi Malaysia, 2016

Bibliographic Details
Main Authors:	Farah Sahira Mohd Khalil, 1993- , author 609191, Praseetha Prabhakaran, supervisor 270598, Fakulti Biosains dan Kejuruteraan Perubatan 538915
Format:
Language:	eng
Published:	Johor Bahru, Johor : Universiti Teknologi Malaysia, 2016
Subjects:	Cisplatin

Similar Items

The effects of cisplatin in triple negative breast cancer cells /
by: Farah Sahira Mohd Khalil, 1993- , author 609191
Published: (2016)

Effect of cisplatin on triple negative breast cancer /
by: Hend Salaheldien Ahmed Elnour, 1986-, author 611422, et al.
Published: (2017)

Effects of cisplatin in cervical cancer cells /
by: Siti Khairunnisa Ishak, 1993-, author 609192, et al.
Published: (2016)

Effects of combined cisplatin and clinacanthus nutans on gene expression of MDA-MB-231 breast cancer cells /
by: Yeo, Zhin Leng, 1994-, author 614715, et al.
Published: (2018)

Effect of cisplatin on triple negative breast cancer /
by: Hend Salaheldien Ahmed Elnour, 1986-, author 611422
Published: (2017)

The effects of taxol in triple negative breast cancer cells /
by: Amirah 'Aqilah Mat Zaid 1993-, author 637479, et al.
Published: (2016)

The anticancer effects of curcumin on triple-negative breast cancer cells /
by: Nur Arifah Husin Basri, 1994-, author 620226, et al.
Published: (2017)

Effects of cisplatin in cervical cancer cells /
by: Siti Khairunnisa Ishak, 1993-, author 609192
Published: (2016)

Effects of combined cisplatin and clinacanthus nutans on gene expression of MDA-MB-231 breast cancer cells /
by: Yeo, Zhin Leng, 1994-, author 614715
Published: (2018)

Effects of Newcastle disease virus infection on cisplatin-resistant breast cancer cell line
by: Jamal, Mohd Hafifi
Published: (2015)

The anticancer effects of retinoic acid on triple negative breast cancer cells /
by: Emirul Iskandar Roslee, 1994- , author 612607, et al.
Published: (2017)

Unveiling the therapeutic potential of anthocyanin/cisplatin-loaded chitosan nanoparticles against breast and liver cancers
by: Mai G. Awad, et al.
Published: (2024-11-01)

Lebanese Cannabis sativa L. extract protects from cisplatin-induced nephrotoxicity in mice by inhibiting podocytes apoptosis
by: Alia Khalil, et al.
Published: (2025-01-01)

Paving the way for better ototoxicity assessments in cisplatin therapy using more reliable animal models
by: Vijayprakash Manickam, et al.
Published: (2025-03-01)

Cytotoxic effects of combined cisplatin and clinacanthus nutans in MDA-MB-231 and MDA-MB-468 triple negative breast cancer cells /
by: Nur Fitriyani Afiqah Abu Bakar, 1990-, author 639805, et al.
Published: (2021)

Potential therapeutic effect of thymoquinone on cisplatin-induced hepatotoxicity in rats
by: Sercan Kaya, et al.
Published: (2024-03-01)

The effects of taxol in cervical cancer cells hela /
by: Anis Atiqah Sakmani, 1993-, author 609188, et al.
Published: (2016)

Cisplatin‐coordinated copolythiophene for synergistic chemotherapy and sonodynamic therapy of tumor
by: Yuanyu Tang, et al.
Published: (2024-09-01)

Deferiprone ameliorates cisplatin induced peripheral neurotoxicity via ferritinophagy adjustment
by: Hanan Seddiek, et al.
Published: (2025-02-01)

Anticancer effects of retinoic acid in cervical cancer cells /
by: Sugania Malar Chinapayan, 1994- , 612588, et al.
Published: (2017)

Renal protective effect of a hydration supplemented with magnesium in patients receiving cisplatin for head and neck cancer
by: Takahiro Kimura, et al.
Published: (2018-02-01)

Cisplatin-Induced Renal Failure Measured by Glomerular Filtration Rate (GFR) with <sup>99</sup>mTc-DTPA Scans in Cancer Patients: A Systematic Review and Meta-Analysis
by: Mansour M. Alqahtani
Published: (2024-11-01)

Synergistic breast cancer therapy with RGD-decorated liposomes co-delivering mir-34a and cisplatin
by: Hassan Bardania, et al.
Published: (2024-11-01)

Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin
by: Pieter Spincemaille, et al.
Published: (2014-10-01)

Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells
by: Wanhong He, et al.
Published: (2024-12-01)

Cytotoxicity of natural and synthetic cannabinoids and their synergistic antiproliferative effects with cisplatin in human ovarian cancer cells
by: Ying Chen, et al.
Published: (2024-11-01)

Recent status of cisplatin in the treatment of advanced cervical cancer: A bibliometric analysis
by: Qiang Huang, et al.
Published: (2025-03-01)

Intraperitoneal CHEMOPERFUSION TREATMENT OF ADVANCED OVARIAN CANCER WITH DIOXADET COMPARED TO CISPLATIN in experimental s
by: V. G. Bespalov, et al.
Published: (2016-02-01)

Mechanistic insights into epithelial-mesenchymal transition mediated cisplatin resistance in ovarian cancer
by: Taha Umair Wani, et al.
Published: (2025-01-01)

Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin
by: Tatpong Sriyapai, et al.
Published: (2022-06-01)

Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor
by: V. G. Bespalov, et al.
Published: (2016-02-01)

Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells
by: Amirhosein Maharati, et al.
Published: (2025-01-01)

Novel therapy modalities combining photodynamic therapy and liposomal cisplatin for pancreatic cancer treatments
by: Jia-Haur Chen, et al.
Published: (2025-03-01)

Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy—A State-of-the-Art Review
by: Olaf Rose, et al.
Published: (2024-12-01)

The anticancer effects of Curcumin on cervical cancer cells /
by: Shafiqah Hanim Muhammad Shakib, 1994- , author 611594, et al.
Published: (2017)

Muscle invasive bladder cancer treated with gemcitabine plus cisplatin as neoadjuvant chemotherapy during the second trimester of pregnancy
by: Takeshi Sasaki, et al.
Published: (2025-03-01)

Curcumin mediates glutathione depletion via metal–organic framework nanocarriers to enhance cisplatin chemosensitivity on esophageal cancer
by: Yunhao Sun, et al.
Published: (2024-12-01)

Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasion
by: Lydia C. Powell, et al.
Published: (2025-02-01)

POLYSACCHARIDES TUSSILAGOFARFARA L. REDUCE MYELOSUPPRESSION INDUCED BY CISPLATIN AND ETOPOSIDE
by: E. A. Safonova, et al.
Published: (2017-09-01)

Insight into the current practice of ototoxicity monitoring during cisplatin therapy
by: N. M. Santucci, et al.
Published: (2021-03-01)